Retinoids in the Management of Head and Neck Cancer. An Update

References

• Boring CC, Squires TS, Tong T. Cancer statistics 1991. Ca 1991; 41: 19–36.
   Google Scholar
• Lippman SM, Hong WK. Retinoid chemoprevention of upper aerodigestive tract carcinogenesis. In: De Vita V, Hellman S, Rosenberg S (eds), Important Advances in Oncology 1992. Philadelphia, JB Lippincott Co, 1992: 93–109.
   Google Scholar
• Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 1989; 17: 691–694.
   Google Scholar
• Sporn M. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 1976; 36: 2699–2702.
   Google Scholar
• Moon RC, Rao KVN, Detrisac CJ, Kelloff GJ. Animal models for chemoprevention of respiratory cancer. J Natl Cancer Inst Monogr 1992; 13: 45–49.
   Google Scholar
• Mori S. The changes in the paraocular glands which follow the administration of diets low in fat-soluble A with notes of the effect of the same diets on the salivary glands and the mucosa of the larynx and trachea. Johns Hopkins Hosp Bull 1922; 33: 357.
   Google Scholar
• Smith DM, Rogers AE, Newberne PM. Vitamin A and benzo (a) pyrene carcinogenesis in the respiratory tract of hamsters fed a semisynthetic diet. Cancer Res 1975; 35: 1485.
   Google Scholar
• Nettesheim P, Williams ML. The influence of vitamin A on the susceptibility of the rat lung to 3-methyl-cholanth-rene. Int J Cancer 1976; 17: 351–357.
   Google Scholar
• Saffiotti U, Montesano R, Sellakumar R et al. Experimental cancer of the lung, inhibition by vitamin A of the induction of tracheobronchial metaplasia and squamous cell tumor. Cancer 1967; 20: 857–864.
   Google Scholar
• Nettesheim P, Cone VW, Snyder C. The influence of retinyl acetate on the postinitiation phase of preneoplastic lung nodules in rats. Cancer Res 1976; 36: 996–1002.
   Google Scholar
• Port CD, Sporn MB, Kaufman DG. Prevention of lung cancer in hamsters by 13-cis-retinoic acid (Abstract). Proc Am Assoc Cancer Res 1975; 16: 21.
   Google Scholar
• Stinson SP, Reznik G, Donahoe R. Effect of three retinoids on tracheal carcinogenesis with N-methyl-N-nitro-sourea in hamsters. J Natl Cancer Inst 1981; 66: 947–951.
   Google Scholar
• Chu EW, Malmgren RA. An inhibitory effect of vitamin A on the induction of tumors of forestomach and cervix in the Syrian hamster by carcinogenic polycyclic hydrocarbons. Cancer Res 1965; 25: 884–895.
   Google Scholar
• Shklar G, Marefat P, Kornhouser A, Trickier DP, Wallace KD. Retinoid inhibition of lingual carcinogenesis. Oral Surg Oral Med Oral Pathol 1980; 49: 325–332.
   Google Scholar
• Shklar G, Schwartz J, Grau D, Trickier DP, Wallace KD. Inhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid. Oral Surg Oral Med Oral Pathol 1980; 49: 325–332.
   Google Scholar
• Boone CW, Kelloff GJ, Malone WE. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. Cancer Res 1990; 50: 2–9.
   Google Scholar
• Chytil F, Ong DE. In: Sporn MB, Roberts AB, Goodman DS (eds). The Retinoids. Orlando: Academic Press 1984; 2: 90–123.
   Google Scholar
• Blomhoff R, Green MH, Berg T et al. Transport and storage of vitamin A. Science 1990; 250: 399–404.
   Google Scholar
• Giguere V, Ong ES, Segui P et al. Identification of a receptor for the morphogen retinoic acid. Nature 1987; 330: 624–629.
   Google Scholar
• Benbroock D, Lernhardt E, Phahl M. A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 1988; 333: 669–672.
   Google Scholar
• Brand N, Petkovich M, Krust A et al. Identification of a second human retinoic acid receptor. Nature 1988; 332: 850–853.
   Google Scholar
• Krust A, Kastner P, Petkovich M et al. A third human retinoic acid receptor, hRAR-β. Proc Natl Acad Sci USA 1989; 86: 5310–5314.
   Google Scholar
• Zelent A, Krust A, Petkovich M et al. Cloning of murine a and , retinoic acid receptor and a novel receptor – predominantly expressed in skin. Nature 1989; 339: 714–717.
   Google Scholar
• Ragsdale CW, Petkovich M, Gates PB et al. Identification of a novel retinoic acid receptor in regenerative tissues of the newt. Nature 1989; 341: 654–657.
   Google Scholar
• Sani BP, Singh RK, Reddy LG, Gaub MP. Isolation, partial purification and characterization of nuclear retinoic acid receptors from chick skin. Arch Biochem Biophys 1990; 283: 107–113.
   Google Scholar
• Mangelsdorf DJ, Ong ES, Dyck JA et al. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990; 345: 224–229.
   Google Scholar
• Mangelsdorf DJ. Umesono K, Kliewer SA et al. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RxR and RAR. Cell 1991; 66: 555–561.
   Google Scholar
• Zhang XK, Hoffman B, Tran PB et al. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 1992; 355: 441–446.
   Google Scholar
• Kliewer SA, Umesono K, Mangelsdorf DJ et al. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin Di signalling. Nature 1992; 335: 446–449.
   Google Scholar
• Bollag W, Holdener EE. Retinoids in cancer prevention and therapy. Ann Oncol 1992; 3: 513–526.
   Google Scholar
• Duester G, Shean ML, Mc Bride MS, Stewart MJ. Retinoic acid response element in the human alcohol dehydrogenase gene ADH 3: Implication for regulation of retinoic acid synthesis. Mol Cell Biol 1991; 11: 1638–1646.
   Google Scholar
• Hofmann SL. Southwestern Internal Medicine Conference: Retinoids. “Differentiation agents” for Cancer Treatment and Prevention. Am J Med Sci 1992; 304: 202–213.
   Google Scholar
• Breitman TR, Selonic S, Collins S. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci 1980; 77: 2936–2940.
   Google Scholar
• Smith MA, Parkinson DR, Cheson BD, Friedman MA. Retinoids is cancer therapy. J Clin Oncol 1992; 10: 839–864.
   Google Scholar
• Sidell N. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 1982; 68: 589–593.
   Google Scholar
• Olsson IL, Breitman TR. Induction of differentiation of the human histiorytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3′:5′-monophosphate-inducing agents. Cancer Res 1982; 42: 3924–3927.
   Google Scholar
• Meyskens F, Fuller B. Characterization of the effects of different retinoids on the growth and differentiation of human melanoma cell lines and selected subclones. Cancer Res 1980; 40: 2194–2196.
   Google Scholar
• Imaizumi M, Breitman TR. Retinoic acid induced differentiation of the human promyelocytic leukemia cell line, HL-60, and fresh human leukemia cells in primary culture: A model for differentiation inducing therapy of leukemia. Eur J Haematol 1987; 38: 289: 302.
   Google Scholar
• Lotan R, Sacks P, Lotan D et al. Differential effects of retinoic acid on the in vitro growth and cell-surface glycoconjugates of 2 human head and neck squamous-cell carcinomas. Int J Cancer 1987; 40: 224–229.
   Google Scholar
• Sacks P, Oke V, Amos B et al. Modulation of growth, differentiation, and glycoprotein synthesis by all-trans retinoic acid in a multicellular tumor spheroid model for squamous carcinoma of the head and neck. Int J Cancer 1989; 44: 926–933.
   Google Scholar
• Tomida M, Yamamoto Y, Hozumi M. Stimulation by interferon of induction of differentiation of human promyelocytic leukemia cells. Biochem Biophys Res Commun 1982; 104: 30–37.
   Google Scholar
• Jetten A, Kim J, Sacks P et al. Inhibition of growth and squamous cell differentiation markers in cultured human head and neck squamous carcinoma cells by all-trans retinoic acid. Int J Cancer 1990; 45: 195–202.
   Google Scholar
• Fisher PB, Grant S. Effects of interferon on differentiation of normal and tumor cells. Pharmac Ther 1985; 27: 143–166.
   Google Scholar
• Hemmi H, Breitman TR. Combinations of recombinant human interferons and retinoic acid synergistically induce differentiation of the human promyelocytic leukemia cell line HL-60. Blood 1987; 69: 501–507.
   Google Scholar
• Kohlhepp EA, Condon ME, Hamburger AW. Recombinant human interferon-a enhancement of retinoic acid-in-duced differentiation of HL-60 cells. Exp Hematol 1987; 15: 414–418.
   Google Scholar
• Trinchieri G, Rosen M, Perussia B. Retinoic acid cooperates with tumor necrosis factor and immune interferon in inducing differentiation and growth inhibition of the human promyelocytic leukemia cell line HL-60. Blood 1987; 69: 1218–1224.
   Google Scholar
• Santini V, Delwel R, Löwenberg B. Terminal granulocytic maturation in acute myeloid leukemia (AML) following granulocyte colony stimulating factor (G-CSF) and retinoic acid (RA) stimulation. Exp Hematol 1989; 17: 646.
   Google Scholar
• Peck R, Bollag W. Potentiation of retinoid-induced differentiation of HL-60 and U 937 cell lines by cytokines. Eur J Cancer 1991; 27: 53–57.
   Google Scholar
• Sacks PG, Oke V, Amos B et al. Modulation of growth, differentiation and glycoprotein synthesis by all-trans retinoic acid in a multicellular tumor spheroid model for squamous cell carcinoma of the head and neck. Int J Cancer 1989; 44: 926–933.
   Google Scholar
• Jetten AM, Kim JS, Sacks PG et al. Inhibition of growth and squamous cell differentiation markers in cultured human head and neck squamous carcinoma cells by all-trans retinoic acid. Int J Cancer 1990; 45: 195–202.
   Google Scholar
• Frey JR, Peck R, Bollag W. Antiproliferative activity of retinoids, interferon-a and their combination in five human transformed cell lines. Cancer Lett 1991; 57: 223–227.
   Google Scholar
• Glick A, McCune B, Abdulkarem N et al. Complex regulation of TGF-, expression by retinoic acid in the vitamin A deficient rat. Development 1991; 111; 1081–1086.
   Google Scholar
• Shapiro SS, Poon JP. Retinoic acid-induced alterations of growth and morphology in an established epithelial line. Exp Cell Res 1979; 119: 349–357.
   Google Scholar
• Kamei H. Effect of retinoic acid on cell-cell adhesiveness in cloned BHK21/C13 cells which form piling-up colonies. Exp Cell Res 1983; 148: 11–20.
   Google Scholar
• Edward M. Effect of retinoids on tumor invasion and metastasis. Pathobiology 1992; 60: 271–277.
   Google Scholar
• Nakajima M, Lotan D, Baig MM et al. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res 1989; 49: 1698–1706.
   Google Scholar
• Hendrix MJC, Wood WR, Seftor EA et al. Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res 1990; 50: 4121–4130.
   Google Scholar
• Bauer EA, Seltzer JL, Eisen AZ. Retinoic acid inhibition of collagenase and gelatinase expression in human skin fibroblast cultures. Evidence for a dual mechanism. J Invest Dermatol 1983; 81: 162–169.
   Google Scholar
• Zerlauth G, Wolf G. Studies on the tumor promoterinduced release of fibronectin from human lung fibroblasts, and its counteraction by retinoic acid. Carcinogenesis 1985; 6: 531–534.
   Google Scholar
• Abergel RP, Meeker CA, Oikarinen H et al. Retinoid modulation of connective tissue metabolism in keloid fibroblast cultures. Arch Dermatol 1985; 121: 632–635.
   Google Scholar
• Varani J, Nickoloff BJ, Dixit VM et al. All-trans retinoic acid stimulates growth of adult human keratinocytes cultured in growth factor-deficient medium, inhibits production of thrombospondin and fibronectin, and reduces adhesion. J Invest Dermatol 1989; 93: 449–454.
   Google Scholar
• Glick AB, Flanders KC, Danielpour D et al. Retinoic acid induces transforming growth factor-beta 2 in cultured keratinocytes and mouse epidermis. Cell Regul 1989; 1: 87–97.
   Google Scholar
• Kochhar DM, Penner JD, Satre MA. Derivation of retinoic acid and metabolites from a teratogenic dose of retinol (vitamin A) in mice. Toxicol Appi Pharmacol 1988; 96: 429–441.
   Google Scholar
• Bhat PV, Lacroix A. Separation of geometric isomers of retinol and retinoic acid in nonaqueous high-performance liquid chromatography. Methods Enzymol 1986; 123: 75–85.
   Google Scholar
• Cullum ME, Zile MH. Metabolism of all-trans-retinoic acid and all-trans retinyl acetate. Demonstration of common physiological metabolites in rat small intestinal mucosa and circulation. J Biol Chem 1985; 260: 10590–10596.
   Google Scholar
• Smith JE, Milch PO, Muto Y, Goodman DS. The plasma transport and metabolism of retinoic acid in the rat. Biochem J 1973; 132: 821–827.
   Google Scholar
• Kalin JR, Starling ME, Hill DL. Disposition of alltrans-retinoic acid in mice following oral doses. Drug Metab Dispos 1981; 9: 196–201.
   Google Scholar
• McPhillips DM, Kalin JR, Hill DL. The pharmacokinetics of all-transretinoic acid and N-(2-hydroxyethyl) retinamide in mice as determined with a sensitive and convenient procedure. Solid-phase extraction and reverse-phase high performance liquid chromatography. Drug Metab Dispos 1987; 15: 207–211.
   Google Scholar
• Wang CC, Campbell S, Fumer RL, Hill DL. Disposition of all-trans- and 13-cis-retinoic acids and n-hydroxyethylretinamide in mice after intravenous administration. Drug Metab Dispos 1980; 8: 8–11.
   Google Scholar
• Shelley RS, Jun HW, Price JC, Cadwallader DE. Blood level studies of all-trans and 13-cis-retinoic acids in rats using different formulations. J Pharm Sci 1982; 71: 904–907.
   Google Scholar
• Klug S, Creech Kraft J, Wildi E et al. Influence of 13-cis and all-trans retinoic acid on rat embryonic development in vitro: correlation with isomerisation and drug transfer to the embryo. Arch Toxicol 1989; 63: 185–192.
   Google Scholar
• Creech Kraft J, Löfberg B, Chahoud I et al. Teratogenicity and placental transfer of all-trans-, 13-cis-, 4-oxo-all-trans, and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in mice. Toxicol Appi Pharmacol 1989; 100: 162–176.
   Google Scholar
• Kalin JR, Wells MJ, Hill DL. Disposition of 13-cis-retinoic acid and N-(2-hydroxyethyl) retinamide in mice after oral doses. Drug Metab Dispos 1982; 10: 391–398.
   Google Scholar
• Hultin TA, May CM, Moon RC. N-(4-hydroxyphenyl)-all-trans retinamide pharmacokinetics in female rats and mice. Drug Metab Dispos 1986; 14: 714–717.
   Google Scholar
• Hill DL, Sani B. Metabolic disposition and development of new chemopreventive retinoids. Drug Metab Rev 1991; 23: 413–438.
   Google Scholar
• Thongnopnua P, Massarella JW, Zimmerman CL. The pharmacokinetics of etretinate and its metabolites in the dog. Drug Metab Dispos 1989; 17: 473–480.
   Google Scholar
• Wang CG, Campbell S, Fumer RL, Hill DL. Disposition of all-trans- and 13-cis-retinoic acids and N-hydroxyethylretinamide in mice after intravenous administration. Drug Metab Dispos 1980; 8: 8–11.
   Google Scholar
• Meyskens F, Goodman G, Alberts D. 13-cis-retinoic acid: Pharmacology, toxicology and clinical application for the prevention and treatment of human cancer. Crit Rev Oncol Hematol 1987; 3: 75–101.
   Google Scholar
• Colburn W, Wane F, Shorter H. Pharmacokinetics of isotretinoin and its major blood metabolite following a single oral dose to man. Eur J Clin Pharmacol 1983; 24: 689–694.
   Google Scholar
• Lippman S, Parkinson D, Itri L et al. 13-cis-retinoic acid and interferon alpha-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992; 24: 235–241.
   Google Scholar
• Brazell RK, Vane FM, Ehmann CW, Colburn WA. Pharmacokinetics of isotretinoin during repetitive dosing to patients. Eur J Clin Pharmacol 1983; 24: 695–702.
   Google Scholar
• Clamon G, Chabot GG, Valeriote F et al. Phase I study and pharmacokinetics of weekly high-dose 13-cis-retinoic acid. Cancer Res 1985; 45: 1874–1878.
   Google Scholar
• Jussawala DJ, Deshpande VA. Evaluation of cancer risk in tobacco chewers and smokers: An epidemiologic assessment. Cancer 1971; 28: 244–252.
   Google Scholar
• Shibuya H, Amagasa T, Seta KI, et al. Leukoplakiaassociated multiple carcinomas in patients with tongue carcinoma. Cancer 1986; 57: 843–846.
   Google Scholar
• Malaowalla AM, Silverman S Jr, Mani NJ, et al. Oral cancer in 57,518 industrial workers of Gujarat, India: A prevalence and follow up study. Cancer 1976; 37: 1882–1886.
   Google Scholar
• Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation: A follow up study of 257 patients. Cancer 1984; 53: 563–568.
   Google Scholar
• Loftus ER, Baric JM, Kapur KK, Chauncey HH. Cigarette smoking and oral leukoplakia in healthy males. Spec Care Dent 1981; 109: 757–760.
   Google Scholar
• Graham S. Epidemiology of retinoids and cancer. J Natl Cancer Inst 1984; 73: 1423–1428.
   Google Scholar
• Olson JA. Serum levels of vitamin A and carotenoids as reflectors of nutritional status. J Natl Cancer Inst 1984; 73: 1439–1444.
   Google Scholar
• Burge-Bottenbley A, Shklar G. Retardation of experimental oral cancer development by retinyl acetate. Nutr Cancer 1983; 5: 121–129.
   Google Scholar
• Huang CC. Effect of retinoids on the growth of squamous cell carcinoma of the palate in rats. Am J Otolaryngol 1986; 7: 55–57.
   Google Scholar
• Koch HF. Biochemical treatment of precancerous oral lesions: The effectiveness of various analogues of retinoic acid. J Maxillofac Surg 1978; 6: 59–63.
   Google Scholar
• Koch HF. Effect of retinoids on precancerous lesions of oral mucosa. In: Orfanos CE, Braun-Flaco O, Farber EM, et al, Eds. Retinoids: Advances in Basic Research and Therapy. Berlin: Springer-Verlag, 1981: 307–312.
   Google Scholar
• Lippman SM, Garewal HS, Meyskens FLJr. Retinoids as potential chemopreventive agents in squamous cell carcinoma of the head and neck. Prev Med 1989; 18: 740–748.
   Google Scholar
• Garewal HS, Meyskens FL Jr, Killen D, et al. Responses of oral leukoplakia to beta-carotene. J Clin Oncol 1990; 8: 1715–1720.
   Google Scholar
• Shah JP, Strong EW, De Cosse JJ, et al. Effect of retinoid on oral leukoplakia. Am J Surg 1983; 146: 466–470.
   Google Scholar
• Hong WK, Endicott J, Itri LM, et al. 13-cis retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986; 315: 1501–1505.
   Google Scholar
• Stich HF, Hornby AP, Mathew B, Sankaranarayanan R, Krishnan Nair M. Response of oral leukoplakias to the administration of vitamin A. Cancer Lett 1988; 40: 93–101.
   Google Scholar
• Lippman SM, Batsakis JG, Toth BB, et al. Comparison of low-dose isotretinoin with beta-carotene to prevent oral carcinogenesis. N Engl J Med 1993; 328: 15–20.
   Google Scholar
• Alberts DS, Coulthard SW, Meyskens FLJr. Regression of agressive laryngeal papillomatosis with 13-cis-retinoic acid (Accutane). J Biol Response Mod 1986; 5: 124–128.
   Google Scholar
• Bichler E. The role of aromatic retinoid in treatment of laryngeal keratinizing disorders and dysplasias. In: Spitzy KH, Karrer K. Eds. Proceedings of the 13th International Congress of Chemotherapy. Vienna: VH Egermann, 1983: 209–229.
   Google Scholar
• Bell R, Hong WK, Itri L, et al. The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: A randomized pilot study. Am J Otolaryngol 1988; 9: 161–164.
   Google Scholar
• Slaughter DP, Southwick IIW, Smejkal W. “Field cancerization” in oral stratification squamous epithelium: Clinical implications of multicentric origin. Cancer 1953; 6: 963–968.
   Google Scholar
• Strong MS, Inceze J, Vaughan CW. Field cancerization in the aerodigestive tract -its etiology, manifestation, and significance. J Otolaryngol 1984; 13: 1–6.
   Google Scholar
• Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 1990; 323: 795–801.
   Google Scholar
• Benner SE, Lippman SM, Earley C, et al. Long-term follow-up: 13-cis retinoic acid prevention of second primary tumors following squamous cell carcinoma of the head and neck. (Abstract). Proc Am Soc Clin Oncol 1993; 12: 278.
   Google Scholar
• Freedman MA. The effect of partial noncompliance on the power of a clinical trial. Control Clin Trials 1990; 11: 157–168.
   Google Scholar
• Briggs RJS, Forastiere AA. Isotretinoin for prevention of second primary squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 1991; 105: 752–754.
   Google Scholar
• Benner SE, Lippman SM, Hong WK. Current status of chemoprevention of head and neck cancer. Oncology 1992; 6: 61–66.
   Google Scholar
• Kramer BS. The Benner/Lippman/Hong article reviewed. Oncology 1992; 6: 66–67.
   Google Scholar
• Lippman SM, Kavanagh JJ, Paredes-Espinoza M et al. 13-cis-retinoic acid plus interferon a-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 1992; 84: 241–245.
   Google Scholar
• Lippman SM, Parkinson DR, Itri LM et al. 13-cis-retinoic acid and interferon a-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992; 84: 235–241.
   Google Scholar
• Braathen LR, McFadden N. Successful treatment of mycosis fungoides with combination of etretinate and human recombinant interferon alfa-2a. J Dermatol Treat 1989; 1: 29–32.
   Google Scholar
• Knobler RM, Trautinger F, Radaszkiewicz T et al. Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids. J Am Acad Dermatol 1991; 24: 247–252.
   Google Scholar
• Nikolaou A, Fountzilas G, Themelis C, Daniilidis J. Treatment of unresectable recurrencies of head and neck carcinomas with interferon-a and retinoids (Abstract). Proceedings of 15th World Congress of Otorhinolaryngology-Head and Neck Surgery. Istanbul 1993: 360.
   Google Scholar
• Weber W, Obrecht JP. Etretinate, lomustine and bleomycin versus lomustine and bleomycin in advanced squamous cell lung carcinoma. Cancer Treat Rep 1983; 67: 847–849.
   Google Scholar
• Zachariae H, Thestrup-Pedersen K. Combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mucosis fungoides: A six-year experience. Acta Derm Venerol (Stockh) 1987; 67: 433–437.
   Google Scholar
• Thatcher N, Blackledge C, Crowther D. Advanced recurrent squamous cell carcinoma of the head and neck. Results of a chemotherapeutic regimen with adriamycin, bleomycin, 5-fluorouracil, methotrexate, and vitamin A. Cancer 1980; 46: 1324–1328.
   Google Scholar
• Mills EED. The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis. Br J Cancer 1988; 57: 416–417.
   Google Scholar
• Van Poppel G. Carotenoids and Cancer: An update with emphasis on human intervention studies. Eur J Cancer 1993; 29 A: 1335–1344.
   Google Scholar
• Grettaz M, Baron A, Siegenhaler G et al. Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta. Biochem J 1990; 272: 391–397.
   Google Scholar